Explore how multi-omics technologies are transforming colorectal cancer research through novel biomarkers, therapeutic targets, and single-cell sequencing approaches.
Explore how integrative analysis of fecal metagenomics and metabolomics is transforming colorectal cancer detection and treatment through cutting-edge microbiome research.
Discover how oral pathogens in colorectal tumor mucosa define three microbiome subtypes that correlate with tumor progression and patient outcomes.
Exploring the role of intratumoral microbiome in early-onset colorectal cancer and its implications for diagnosis and treatment.
Exploring the revolutionary understanding of how tumor genomics and gut microbiome interact in colorectal cancer development and progression.
Discover how genetic variants in the LPS receptor complex and TLR4 expression levels predict cetuximab efficacy in metastatic colorectal cancer patients.
Exploring how volatile organic compounds and gut microbiome profiling could transform colorectal cancer detection through non-invasive methods.
Discover how gut microbiome changes predict colorectal cancer progression and prognosis in this groundbreaking study.